UNIGENE LABORATORIES INC Share-based Payment Arrangement, Expense
UNIGENE LABORATORIES INC reported Share-based Payment Arrangement, Expense of $23.00 thousand for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2013-03-15
- UNIGENE LABORATORIES INC share-based payment arrangement, expense for the quarter ending 2012-12-31 was $2.55K, a 99.29% decline year-over-year.
- UNIGENE LABORATORIES INC share-based payment arrangement, expense for the quarter ending 2012-09-30 was $2.15K.
- UNIGENE LABORATORIES INC share-based payment arrangement, expense for the quarter ending 2012-06-30 was $12.10K.
- UNIGENE LABORATORIES INC share-based payment arrangement, expense for the quarter ending 2012-03-31 was $6.20K.
- UNIGENE LABORATORIES INC share-based payment arrangement, expense for fiscal 2012 was $23.00K, a 94.12% decline from fiscal 2011.
- UNIGENE LABORATORIES INC share-based payment arrangement, expense for fiscal 2011 was $391.00K, a 60.91% increase from fiscal 2010.
- UNIGENE LABORATORIES INC share-based payment arrangement, expense for fiscal 2010 was $243.00K.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month | Share-based Payment Arrangement, Expense 15 month |
|---|---|---|---|---|---|
| 2012-12-31 | $2.55K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $4.70K derived: sum of 2 quarters · filed 2013-03-15 | $16.80K derived: sum of 3 quarters · filed 2013-03-15 | $23.00K 10-K · filed 2013-03-15 | |
| 2012-09-30 | $2.15K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-01-31 | $14.25K derived: sum of 2 quarters · filed 2013-01-31 | $20.45K 10-Q · filed 2013-01-31 | $380.08K derived: sum of 4 quarters · filed 2013-03-15 | |
| 2012-06-30 | $12.10K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2013-01-31 | $18.30K 10-Q/A · filed 2013-01-31 | $377.93K derived: sum of 3 quarters · filed 2013-03-15 | ||
| 2012-03-31 | $6.20K 10-Q/A · filed 2013-01-31 | $365.83K derived: sum of 2 quarters · filed 2013-03-15 | $6.20K 10-Q · filed 2012-05-10 | ||
| 2011-12-31 | $359.63K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $391.00K 10-K · filed 2013-03-15 | |||
| 2011-09-30 | $31.37K 10-Q · filed 2011-11-09 | ||||
| 2010-12-31 | $243.00K 10-K · filed 2013-03-15 |